Healthpeak Properties (NASDAQ:PEAK) Expected to Post Quarterly Sales of $685.36 Million

Equities research analysts expect Healthpeak Properties (NASDAQ:PEAK) to report sales of $685.36 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Healthpeak Properties’ earnings. The lowest sales estimate is $655.70 million and the highest is $715.01 million. Healthpeak Properties reported sales of $491.57 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 39.4%. The company is scheduled to announce its next quarterly earnings report on Wednesday, July 29th.

According to Zacks, analysts expect that Healthpeak Properties will report full-year sales of $2.47 billion for the current year, with estimates ranging from $2.15 billion to $2.72 billion. For the next year, analysts expect that the business will report sales of $2.62 billion, with estimates ranging from $2.21 billion to $2.91 billion. Zacks’ sales averages are an average based on a survey of research firms that that provide coverage for Healthpeak Properties.

Healthpeak Properties (NASDAQ:PEAK) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.10. The firm had revenue of $585.20 million for the quarter, compared to the consensus estimate of $531.36 million. The business’s revenue for the quarter was up 34.2% compared to the same quarter last year.

Several equities research analysts recently weighed in on the stock. Barclays reiterated a “buy” rating and issued a $28.00 target price on shares of Healthpeak Properties in a research note on Wednesday, April 8th. Bank of America cut shares of Healthpeak Properties from a “buy” rating to a “neutral” rating in a research note on Monday, March 23rd. BMO Capital Markets reiterated a “buy” rating and issued a $30.00 target price on shares of Healthpeak Properties in a research note on Friday, May 22nd. KeyCorp reduced their target price on shares of Healthpeak Properties from $37.00 to $30.00 and set an “overweight” rating for the company in a research note on Tuesday, April 21st. Finally, Royal Bank of Canada cut their price target on shares of Healthpeak Properties from $32.00 to $27.00 in a research note on Thursday, May 14th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $28.00.

Several institutional investors have recently modified their holdings of PEAK. Cohen & Steers Inc. acquired a new stake in shares of Healthpeak Properties in the fourth quarter valued at approximately $347,517,000. Geode Capital Management LLC bought a new position in Healthpeak Properties in the fourth quarter valued at approximately $338,518,000. Barrow Hanley Mewhinney & Strauss LLC bought a new position in Healthpeak Properties in the fourth quarter valued at approximately $319,827,000. Nuveen Asset Management LLC bought a new position in Healthpeak Properties in the fourth quarter valued at approximately $285,928,000. Finally, Bank of New York Mellon Corp bought a new position in Healthpeak Properties in the fourth quarter valued at approximately $272,706,000.

PEAK stock traded up $0.69 during mid-day trading on Monday, reaching $27.18. 4,414,345 shares of the stock traded hands, compared to its average volume of 4,714,025. Healthpeak Properties has a 52 week low of $18.63 and a 52 week high of $37.93. The stock has a 50-day simple moving average of $25.67.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles.

Read More: Are all No-Load Funds Equal?

Get a free copy of the Zacks research report on Healthpeak Properties (PEAK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthpeak Properties (NASDAQ:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.